logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
A

Andrew Hill

university of liverpool

59H-index
307Paper Count
1.2WCitation Count
Published Papers 115
Publication Date
logo
Is It Time to Reassess the Target Age of Human Papillomavirus Vaccination Globally?
errClinical Infectious Diseases
IF7.3
err2025-12-09
err0
errOAAI
errEdie Brassington; Cassandra Fairhead; Andrew Hill; null
errShare
errSave
Research and development spending versus revenues after approval for CFTR modulators
errJournal of Cystic Fibrosis
IF6
err2025-10-24
err0
errOAAI
errJonathan Guo; Grace Hennessy; Benedict Young; Andrew Hill
errShare
errSave
Intracranial arterial calcification as a marker of stroke risk and worse stroke outcomes in adults: A systematic review and meta-analysis
errInternational Journal of Stroke
IF8.7
err2025-08-22
err0
errOAAI
errSandra Elsheikh; Stephen McKeever; Greg J Irving; Andrew M Hill; Gregory YH Lip; Azmil H Abdul-Rahim
errShare
errSave
Could reduced dosing maintain more people on antiretrovirals after the sudden cuts in USAID funding? A crisis response
errAIDS
IF3.1
err2025-04-23
err0
PREAI
errHill, A; Fairhead, C; Manalu, S; Venter, F; Collins, S; Landman, R; Pozniakz, A; Martinez, E
errShare
errSave
The Need for Lenacapavir Compulsory Licences in Ending the HIV Epidemic
errCLINICAL INFECTIOUS DISEASES
IF7.3
err2025-04-01
err0
PREAI
errHill, Andrew; Siedner, Mark J.; Fairhead, Cassandra; Venter, Francois
errShare
errSave
Safety and efficacy of long-acting cabotegravir/rilpivirine versus standard oral antiretroviral therapy: a systematic review and meta-analysis
errJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
IF3.6
err2025-01-08
err0
errOAAI
errManalu, Samuel Bungaran Partahi Saud; Navarro, Andrea Perez; Fairhead, Cassandra; Hill, Andrew
errShare
errSave
Virologic Failure and Emergent Integrase Strand Transfer Inhibitor Drug Resistance With Long-Acting Cabotegravir for HIV Treatment: A Meta-analysis
errCLINICAL INFECTIOUS DISEASES
IF7.3
err2024-12-26
err0
PREAI
errNavarro, Andrea Perez; Nutt, Cameron T.; Siedner, Mark J.; Mccluskey, Suzanne M.; Hill, Andrew
errShare
errSave
The long wait for long-acting HIV prevention and treatment formulations
errLANCET HIV
IF13
err2024-10-01
err5
PREAI
errVenter, Willem Daniel Francois; Gandhi, Monica; Sokhela, Simiso; Sikwese, Kenly; Bygrave, Helen; Da Gama, Louis; Mphothulo, Ndiviwe; Jamieson, Lise; Siedner, Mark J.; Pozniak, Anton L.; Rojo, Pablo; Baptiste, Solange L.; Wambui, Jacque; Meyer-Rath, Gesine; Honermann, Brian; Warren, Mitchell; Bekker, Linda-Gail; Sinxadi, Phumla; Collins, Simon; Burry, Jessica; Moller, Karlien; Clayden, Polly; Owen, Andrew; Hill, Andrew
errShare
errSave
Challenges for Novel Antiretroviral Development in an Era of Widespread tenofovir-disoproxil/lamivudine (or emtricitabine)/dolutegravir availability (TLD) Availability
errCLINICAL INFECTIOUS DISEASES
IF7.3
err2024-07-11
err0
PREAI
errFairhead, Cassandra; Levi, Jacob; Hill, Andrew
errShare
errSave
Should we continue to use tenofovir disoproxil fumarate/lamivudine/dolutegravir for treatment of pregnant women? Interpreting the PROMISE trial
errAIDS
IF3.1
err2024-06-27
err0
PREAI
errHill, Andrew M.; Elbirt, Daniel
errShare
errSave
Which Form of Tenofovir Should Be Used Worldwide: Tenofovir Disoproxil Fumarate or Tenofovir Alafenamide?
errCLINICAL INFECTIOUS DISEASES
IF7.3
err2024-04-12
err3
PREAI
errHill, Andrew
errShare
errSave
WHO hepatitis C elimination targets: the global equity challenge
errLANCET GASTROENTEROLOGY & HEPATOLOGY
IF38.6
err2024-04-01
err6
PREAI
errHeath, Katherine; Hill, Andrew
errShare
errSave
Final 192-Week Efficacy and Safety Results of the ADVANCE Trial, Comparing 3 First-line Antiretroviral Regimens
errOPEN FORUM INFECTIOUS DISEASES
IF3.8
err2024-01-24
err13
errOAAI
errSokhela, Simiso; Venter, Willem D. F.; Bosch, Bronwyn; Woods, Joana; Mccann, Kaitlyn; Akpomiemie, Godspower; Chandiwana, Nomathemba; Mashabane, Nkuli; Tembo, Angela; Simmons, Bryony; Lalla-Edward, Samanta; Siedner, Mark J.; Sinxadi, Phumla; Hermans, Lucas; Fairlie, Lee; Vos, Alinda; Abrams, Elaine; Manne-Goehler, Jennifer M.; Moorhouse, Michelle; Clayden, Polly; Norris, Shane; Qavi, Ambar; Chersich, Matthew; Masenya, Masebole; Arulappan, Natasha; Hill, Andrew
errShare
errSave
Combined Test and Treat Campaigns for Human Immunodeficiency Virus, Hepatitis B, and Hepatitis C: A Systematic Review to Provide Evidence to Support World Health Organization Treatment Guidelines
errOPEN FORUM INFECTIOUS DISEASES
IF3.8
err2024-01-11
err3
errOAAI
errBeard, Natasha; Hill, Andrew
errShare
errSave
Dual spatially resolved transcriptomics for human host-pathogen colocalization studies in FFPE tissue sections
errGENOME BIOLOGY
IF9.4
err2023-10-19
err8
errOAAI
errSounart, Hailey; Lazar, Eniko; Masarapu, Yuvarani; Wu, Jian; Varkonyi, Tibor; Glasz, Tibor; Kiss, Andras; Borgstrom, Erik; Hill, Andrew; Rezene, Sefanit; Gupta, Soham; Jurek, Aleksandra; Niesnerova, Anezka; Druid, Henrik; Bergmann, Olaf; Giacomello, Stefania
errShare
errSave
Global Human Immunodeficiency Virus Incidence Analysis and Implications for Affordability Using Long-Acting Cabotegravir Versus Continuous and Event-Driven Oral Preexposure Prophylaxis
errCLINICAL INFECTIOUS DISEASES
IF7.3
err2023-09-04
err5
errOAAI
errSharma, Ishani; Hill, Andrew
errShare
errSave
Weight Gain After HIV Therapy Initiation: Pathophysiology and Implications
errJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
IF5.1
err2023-07-12
err18
errOAAI
errChandiwana, Nomathemba C.; Siedner, Mark J.; Marconi, Vincent C.; Hill, Andrew; Ali, Mohammed K.; Batterham, Rachel L.; Venter, Willem Daniel Francois
errShare
errSave
Standard-dose versus double-dose dolutegravir in HIV- associated tuberculosis in South Africa (RADIANT-TB) : a phase 2, non-comparative, randomised controlled trial
errLANCET HIV
IF13
err2023-07-01
err21
errOAAI
errGriesel, Rulan; Zhao, Ying; Simmons, Bryony; Omar, Zaayid; Wiesner, Lubbe; Keene, Claire M.; Hill, Andrew M.; Meintjes, Graeme; Maartens, Gary
errShare
errSave
Estimated minimum prices and lowest available national prices for antiobesity medications: Improving affordability and access to treatment
errOBESITY
IF4.7
err2023-02-23
err28
errOAAI
errLevi, Jacob; Wang, Junzheng; Venter, Francois; Hill, Andrew
errShare
errSave
Initial Supplementary Dose of Dolutegravir in Second-Line Antiretroviral Therapy: A Noncomparative, Double-Blind, Randomized Placebo-Controlled Trial
errCLINICAL INFECTIOUS DISEASES
IF7.3
err2023-01-16
err4
errOAAI
errZhao, Ying; Griesel, Rulan; Omar, Zaayid; Simmons, Bryony; Hill, Andrew; van Zyl, Gert; Keene, Claire; Maartens, Gary; Meintjes, Graeme
errShare
errSave

Research Directions

The data has not been retrieved yet.
Co-authors
Cooperation Journals
L
Linda‐Gail Bekker
H-index: 111 · Papers: 1.0K
A
Anthony Rodgers
H-index: 108 · Papers: 631
S
Shiv Kumar Sarin
H-index: 107 · Papers: 1.4K
A
Andrew Phillips
H-index: 107 · Papers: 937
C
Caroline Sabin
H-index: 107 · Papers: 1.1K
View more